Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-06-05, Stock:ABBV, The news for the past five days is as follows:
2019-05-29: nan
2019-05-30: NEWS1: 3 Top Gene Therapy Stocks That Could Soar.NEWS2: 3 Top Gene Therapy Stocks That Could Soar.NEWS3: 3 Top Gene Therapy Stocks That Could Soar.NEWS4: The Inverted Yield Curve Should Make Investors Pivot, Not Panic.NEWS5: The Inverted Yield Curve Should Make Investors Pivot, Not Panic.NEWS6: Notable ETF Inflow Detected - DGRO, ABBV, UTX, BMY.NEWS7: Notable ETF Inflow Detected - DGRO, ABBV, UTX, BMY.NEWS8: The Inverted Yield Curve Should Make Investors Pivot, Not Panic.NEWS9: AbbVie Presents Results from Several Studies and Clinical Trials Investigating Medicines Across More than 15 Cancers at the 2019 ASCO and EHA Meetings.NEWS10: AbbVie's MAVIRET™ now listed in New Brunswick.
2019-05-31: NEWS1: Notable Friday Option Activity: MSFT, ABBV, LRCX.NEWS2: Notable Friday Option Activity: MSFT, ABBV, LRCX.NEWS3: Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio.NEWS4: Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio.NEWS5: Vertex Selects Triple Combo Regimen for Regulatory Submission.NEWS6: Vertex Selects Triple Combo Regimen for Regulatory Submission.NEWS7: Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio.NEWS8: Comparing AbbVie’s and Amgen’s 2019 Revenue Growth Trajectories.NEWS9: Vertex Selects Triple Combo Regimen for Regulatory Submission.
2019-06-03: NEWS1: AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know.
2019-06-04: NEWS1: Merck's Antibiotic Zerbaxa Gets FDA Nod for New Indication.NEWS2: Merck's Antibiotic Zerbaxa Gets FDA Nod for New Indication.NEWS3: AbbVie Presents Data from Venetoclax Chemotherapy-Free Combination Regimen for Patients with Previously Untreated Chronic Lymphocytic Leukemia.NEWS4: Merck's Antibiotic Zerbaxa Gets FDA Nod for New Indication.NEWS5: AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know.NEWS6: AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know.

Answer: Rise